Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FDS✓SelectedUSD · FDSGSK vs FDS performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs FDS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.4%
FDS return
-23.9%
Excess return
+70.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioFDSExcessAlpha
1D-0.1%-0.2%+0.1%-0.1%
7D-1.3%+1.7%-3.0%-1.5%
30D+2.7%+10.1%-7.4%+1.5%
3M+2.7%+17.6%-14.9%+0.5%
6M+3.3%+57.6%-54.3%-2.7%
YTD+6.5%+16.1%-9.6%+5.2%
1Y+10.7%+23.4%-12.8%+7.9%
3Y+64.4%-25.8%+90.1%+77.9%
All+46.4%-23.9%+70.2%+52.5%

Cumulative growth

Daily Returns

Daily percentage return beside FDS.

Daily Out/Under-Performance

Portfolio return minus FDS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FDS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded FDS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling